Furthermore, our results suggest that CUTS can effectively discern TDP-43 LOF induced by pathological phase transitions or mislocalization, a critical aspect in the context of neurodegenerative diseases containing TDP-43 pathology, such as ALS and FTLD. This evidence concerns the gene TARDBP and neurodegenerative disease.